{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:23:37Z","timestamp":1791638617966,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03037-3","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:42:57Z","timestamp":1739302977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimization of Capecitabine-Loaded Niosomes Using Factorial Design: An Approach for Enhanced Drug Release and Cytotoxicity in Breast Cancer"],"prefix":"10.1208","volume":"26","author":[{"given":"Vidya","family":"Sabale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-2500","authenticated-orcid":false,"given":"Ashwini","family":"Ingole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutuja","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafulla","family":"Sabale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"3037_CR1","first-page":"7","volume":"1","author":"F Aguilera","year":"2017","unstructured":"Aguilera F. Neoplasia in Mollusks: What Does it Tell us about Cancer in Humans? - A Review. J Genet Disord. 2017;1:7.","journal-title":"J Genet Disord"},{"key":"3037_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1383\/wohm.2006.3.1.36","volume":"3","author":"HM Sweetland","year":"2006","unstructured":"Sweetland HM. Adjuvant therapy for breast cancer. Women\u2019s Heal Med. 2006;3:36\u20139. https:\/\/doi.org\/10.1383\/wohm.2006.3.1.36.","journal-title":"Women\u2019s Heal Med"},{"key":"3037_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5:77\u2013106. https:\/\/doi.org\/10.1016\/j.gendis.2018.05.001.","journal-title":"Genes Dis"},{"key":"3037_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40261-018-0655-z","volume":"38","author":"EC Tampaki","year":"2018","unstructured":"Tampaki EC, Tampakis A, Alifieris CE, Krikelis D, Pazaiti A, Kontos M, et al. Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally\/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study. Clin Drug Investig. 2018;38:639\u201348. https:\/\/doi.org\/10.1007\/s40261-018-0655-z.","journal-title":"Clin Drug Investig"},{"key":"3037_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s002800050043","volume":"45","author":"J Sch\u00fcller","year":"2000","unstructured":"Sch\u00fcller J, Cassidy J, Dumont E, Roos B, Weidekamm E, Reigner B, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol. 2000;45:291\u20137. https:\/\/doi.org\/10.1007\/s002800050043.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3037_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/21691401.2018.1559179","volume":"47","author":"R Nazari-Vanani","year":"2019","unstructured":"Nazari-Vanani R, Karimian K, Azarpira N, Heli H. Capecitabine-loaded nanoniosomes and evaluation of anticancer efficacy. Artif Cells, Nanomedicine Biotechnol. 2019;47:420\u20136. https:\/\/doi.org\/10.1080\/21691401.2018.1559179.","journal-title":"Artif Cells, Nanomedicine Biotechnol"},{"key":"3037_CR7","doi-asserted-by":"publisher","first-page":"104600","DOI":"10.1016\/j.tiv.2019.104600","volume":"61","author":"C Hepokur","year":"2019","unstructured":"Hepokur C, Kariper IA, Misir S, Ay E, Tunoglu S, Ersez MS, et al. Silver nanoparticle\/capecitabine for breast cancer cell treatment. Toxicol Vitr. 2019;61:104600. https:\/\/doi.org\/10.1016\/j.tiv.2019.104600.","journal-title":"Toxicol Vitr"},{"key":"3037_CR8","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.2147\/IJN.S123437","volume":"12","author":"D Wu","year":"2017","unstructured":"Wu D, Si M, Xue HY, Wong HL. Nanomedicine applications in the treatment of breast cancer: Current state of the art. Int J Nanomedicine. 2017;12:5879\u201392. https:\/\/doi.org\/10.2147\/IJN.S123437.","journal-title":"Int J Nanomedicine"},{"key":"3037_CR9","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1002\/jcb.29651","volume":"121","author":"M Ghafari","year":"2020","unstructured":"Ghafari M, Haghiralsadat F, Khanamani Falahati-pour S, Zavar RJ. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy. J Cell Biochem. 2020;121:3584\u201392. https:\/\/doi.org\/10.1002\/jcb.29651.","journal-title":"J Cell Biochem"},{"issue":"7","key":"3037_CR10","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/ph15070816","volume":"15","author":"SW El-Far","year":"2022","unstructured":"El-Far SW, El-Enin HAA, Abdou EM, Nafea OE, Abdelmonem R. Targeting colorectal cancer cells with niosomes systems loaded with two anticancer drugs models; comparative in vitro and anticancer studies.\u00a0Pharm. 2022;15(7):816. https:\/\/doi.org\/10.3390\/ph15070816.","journal-title":"Pharmaceuticals"},{"key":"3037_CR11","doi-asserted-by":"publisher","first-page":"101854","DOI":"10.1016\/j.jddst.2020.101854","volume":"59","author":"A Rezaeiroshan","year":"2020","unstructured":"Rezaeiroshan A, Saeedi M, Morteza-semnani K, Akbari J. Development of trans- Ferulic acid niosome\u202f: an optimization and an in-vivo study. J Drug Deliv Sci Technol. 2020;59:101854. https:\/\/doi.org\/10.1016\/j.jddst.2020.101854.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3037_CR12","first-page":"323","volume":"73","author":"VC Okore","year":"2011","unstructured":"Okore VC, Attama AA, Ofokansi KC, Esimone CO, Onuigbo EB. Formulation and Evaluation of Niosomes. Indian J Pharm Sci. 2011;73:323\u20138.","journal-title":"Indian J Pharm Sci"},{"key":"3037_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopha.2017.06.043","volume":"93","author":"M Qumbar","year":"2017","unstructured":"Qumbar M, Ameeduzzafar, Imam SS, Ali J, Ahmad J, Ali A. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity. Biomed Pharmacother. 2017;93:255\u201366. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.043.","journal-title":"Biomed Pharmacother"},{"key":"3037_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3797\/scipharm.1201-03","volume":"80","author":"L Thomas","year":"2012","unstructured":"Thomas L, Viswanad V. Formulation and optimization of clotrimazole-loaded proniosomal gel using 3 2 factorial design. Sci Pharm. 2012;80:731\u201348. https:\/\/doi.org\/10.3797\/scipharm.1201-03.","journal-title":"Sci Pharm"},{"key":"3037_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40005-014-0121-8","volume":"44","author":"H Abdelkader","year":"2014","unstructured":"Abdelkader H, Farghaly U, Moharram H. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug. J Pharm Investig. 2014;44:329\u201337. https:\/\/doi.org\/10.1007\/s40005-014-0121-8.","journal-title":"J Pharm Investig"},{"key":"3037_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1208\/s12249-012-9805-4","volume":"13","author":"Z Sezgin-Bayindir","year":"2012","unstructured":"Sezgin-Bayindir Z, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. AAPS PharmSciTech. 2012;13:826\u201335. https:\/\/doi.org\/10.1208\/s12249-012-9805-4.","journal-title":"AAPS PharmSciTech"},{"key":"3037_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.biopha.2017.01.083","volume":"88","author":"P Negi","year":"2017","unstructured":"Negi P, Aggarwal M, Sharma G, Rathore C, Sharma G, Singh B, et al. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s). Biomed Pharmacother. 2017;88:480\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.083.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3037_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics12030246","volume":"12","author":"P Shah","year":"2020","unstructured":"Shah P, Goodyear B, Haq A, Puri V, Michniak-Kohn B. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. Pharm. 2020;12(3):246. https:\/\/doi.org\/10.3390\/pharmaceutics12030246.","journal-title":"Pharmaceutics"},{"key":"3037_CR19","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.3390\/app10155341","volume":"10","author":"TM Shehata","year":"2020","unstructured":"Shehata TM, Nair AB, Al-dhubiab BE, Shah J, Jacob S, Alhaider IA, et al. Vesicular emulgel based system for transdermal delivery of insulin\u202f: factorial design and in vivo evaluation. Appl Sci. 2020;10:5341.","journal-title":"Appl Sci"},{"key":"3037_CR20","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.biopha.2017.11.073","volume":"97","author":"S Alam","year":"2018","unstructured":"Alam S, Ahad A, Abidin L, Aqil M, Rasool S. Embelin-loaded oral niosomes ameliorate streptozotocin-induced diabetes in Wistar rats. Biomed Pharmacother. 2018;97:1514\u201320. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.073.","journal-title":"Biomed Pharmacother"},{"key":"3037_CR21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1080\/03639045.2018.1445264","volume":"44","author":"N Dudhipala","year":"2018","unstructured":"Dudhipala N, Puchchakayala G. Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation. Drug Dev Ind Pharm. 2018;44:1572\u201382. https:\/\/doi.org\/10.1080\/03639045.2018.1445264.","journal-title":"Drug Dev Ind Pharm"},{"key":"3037_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/08982104.2019.1652646","volume":"30","author":"D Mohanty","year":"2020","unstructured":"Mohanty D, Rani MJ, Haque MA, Bakshi V, Jahangir MA, Imam SS, et al. Preparation and evaluation of transdermal naproxen niosomes: formulation optimization to preclinical anti-inflammatory assessment on murine model. J Liposome Res. 2020;30:377\u201387. https:\/\/doi.org\/10.1080\/08982104.2019.1652646.","journal-title":"J Liposome Res"},{"key":"3037_CR23","doi-asserted-by":"publisher","first-page":"102035","DOI":"10.1016\/j.jddst.2020.102035","volume":"60","author":"J Akbari","year":"2020","unstructured":"Akbari J, Saeedi M, Enayatifard R, Morteza-Semnani K, Hassan Hashemi SM, Babaei A, et al. Curcumin Niosomes (curcusomes) as an alternative to conventional vehicles: A potential for efficient dermal delivery. J Drug Deliv Sci Technol. 2020;60:102035. https:\/\/doi.org\/10.1016\/j.jddst.2020.102035.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3037_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/2230-973x.107002","volume":"2","author":"S Shirsand","year":"2012","unstructured":"Shirsand S, Kanani K, Keerthy D, Nagendrakumar D, Para M. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig. 2012;2:201. https:\/\/doi.org\/10.4103\/2230-973x.107002.","journal-title":"Int J Pharm Investig"},{"key":"3037_CR25","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jps.21944","volume":"99","author":"ZS Bayindir","year":"2010","unstructured":"Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010;99:2049\u201360.","journal-title":"J Pharm Sci"},{"key":"3037_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1691\/ph.2010.0138","volume":"65","author":"H Abdelkader","year":"2010","unstructured":"Abdelkader H, Ismail S, Kamal A, Alany RG. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride\u202f: Physicochemical characterization. Pharmazie. 2010;65:811\u20137. https:\/\/doi.org\/10.1691\/ph.2010.0138.","journal-title":"Pharmazie"},{"key":"3037_CR27","doi-asserted-by":"publisher","first-page":"129315","DOI":"10.1016\/j.foodchem.2021.129315","volume":"351","author":"P Thiengkaew","year":"2021","unstructured":"Thiengkaew P, Thanitwatthanasak S, Srisala S, Jittorntrum B, Chunhabundit R. Response surface optimization of microfluidic formulations of nanobilosomes for enhancement of aqueous solubility, digestive stability, and cellular antioxidant activity of mangiferin. Food Chem. 2021;351:129315. https:\/\/doi.org\/10.1016\/j.foodchem.2021.129315.","journal-title":"Food Chem"},{"key":"3037_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06955-w","volume":"7","author":"HB Mohamed","year":"2017","unstructured":"Mohamed HB, El-shanawany SM, Hamad MA. Niosomes\u202f: A Strategy toward Prevention of Clinically Significant Drug Incompatibilities. Sci Rep. 2017;7:1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-06955-w.","journal-title":"Sci Rep"},{"key":"3037_CR29","doi-asserted-by":"publisher","first-page":"41503","DOI":"10.1038\/srep41503","volume":"7","author":"MG Arafa","year":"2017","unstructured":"Arafa MG, Ayoub BM. DOE Optimization of Nano-based Carrier of Pregabalin as Hydrogel\u202f: New Therapeutic & Chemometric Approaches for Controlled Drug Delivery Systems. Nat Publ Gr. 2017;7:41503. https:\/\/doi.org\/10.1038\/srep41503.","journal-title":"Nat Publ Gr"},{"key":"3037_CR30","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3762\/bjnano.10.214","volume":"10","author":"BR Jermy","year":"2019","unstructured":"Jermy BR, Ravinayagam V, Alamoudi WA, Almohazey D, Dafalla H, Allehaibi LH, et al. Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe2O4\/silica\/cisplatin nanocomposite formulation. Beilstein J Nanotechnol. 2019;10:2217\u201328. https:\/\/doi.org\/10.3762\/bjnano.10.214.","journal-title":"Beilstein J Nanotechnol"},{"key":"3037_CR31","doi-asserted-by":"publisher","unstructured":"Manjappa AS, Kumbhar PS, Kasabe R, Diwate SK, Disouza JI. Ameliorated in vitro anticancer efficacy of methotrexate d-\u03b1-Tocopheryl polyethylene glycol 1000 succinate ester against breast cancer cells. Futur J Pharm Sci. 2019;5. https:\/\/doi.org\/10.1186\/s43094-019-0013-x.","DOI":"10.1186\/s43094-019-0013-x"},{"key":"3037_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-022-03526-z","volume":"22","author":"B Kis","year":"2022","unstructured":"Kis B, Pavel IZ, Avram S, Moaca EA, Herrero San Juan M, Schwiebs A, et al. Antimicrobial activity, in vitro anticancer effect (MCF-7 breast cancer cell line), antiangiogenic and immunomodulatory potentials of Populus nigra L. buds extract. BMC Complement Med Ther. 2022;22:1\u201324. https:\/\/doi.org\/10.1186\/s12906-022-03526-z.","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"3037_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43094-023-00494-0","volume":"9","author":"DS Gaikwad","year":"2023","unstructured":"Gaikwad DS, Chougale RD, Patil KS, Disouza JI, Hajare AA. Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer. Futur J Pharm Sci. 2023;9(1):43. https:\/\/doi.org\/10.1186\/s43094-023-00494-0.","journal-title":"Futur J Pharm Sci"},{"key":"3037_CR34","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.3390\/ijms23179668","volume":"26","author":"BA Witika","year":"2022","unstructured":"Witika BA, Bassey KE, Demana PH, Siwe-Noundou XPM. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications. Int J Mol Sci. 2022;26:9668.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3037_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/959741","volume":"1","author":"S Kamboj","year":"2014","unstructured":"Kamboj S, Saini V, Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (Niosomes) for oral bioavailability enhancement. Sci World J. 2014;1(1):959741. https:\/\/doi.org\/10.1155\/2014\/959741.","journal-title":"Sci World J"},{"key":"3037_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1567201817666200214111815","volume":"17","author":"P Patel","year":"2020","unstructured":"Patel P, Barot TKP. Formulation, Characterization and In-vitro and In-vivo Evaluation of Capecitabine Loaded Niosomes. Curr Drug Deliv. 2020;17:257\u201365.","journal-title":"Curr Drug Deliv"},{"key":"3037_CR37","first-page":"1504","volume":"4","author":"B Anbarasan","year":"2013","unstructured":"Anbarasan B, Rekha S , Elango K, Shriya B, Ramaprabhu S. Optimization of the formulation and in-vitro evaluation of capecitabine niosomes for the treatment of colon cancer. Int J Pharm Sci Drug Res. 2013;4:1504\u201313.","journal-title":"Int J Pharm Sci Drug Res"},{"key":"3037_CR38","first-page":"23","volume":"2","author":"B Sam","year":"2021","unstructured":"Sam B, Charan P, Polala B, Bindhu GH, Parupati P. Design and Characterization of Famciclovir Drug Loading Niosomes. Int J Res Publ Rev. 2021;2:23\u201333.","journal-title":"Int J Res Publ Rev"},{"key":"3037_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1691\/ph.2019.8168","volume":"74","author":"BA Witika","year":"2019","unstructured":"Witika BA, Walker RB. Development, manufacture and characterization of niosomes for the delivery for nevirapine. Pharmazie. 2019;74:91\u20136. https:\/\/doi.org\/10.1691\/ph.2019.8168.","journal-title":"Pharmazie"},{"key":"3037_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"K Karim","year":"2010","unstructured":"Karim K, Mandal A, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1:374\u201380. https:\/\/doi.org\/10.4103\/0110-5558.76435.","journal-title":"J Adv Pharm Technol Res"},{"key":"3037_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1567201814666170224141548","volume":"15","author":"MS El-Ridy","year":"2017","unstructured":"El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation. Curr Drug Deliv. 2017;15:122\u201333. https:\/\/doi.org\/10.2174\/1567201814666170224141548.","journal-title":"Curr Drug Deliv"},{"key":"3037_CR42","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.13040\/IJPSR.0975-8232.11(5).2356-65","volume":"11","author":"AA Hajare","year":"2020","unstructured":"Hajare AA, Velapure PD, Rathod PN, Patil KS, Chopade SS. Formulation and Evaluation of Solid Lipid Nanoparticle Gel for Topical Delivery of Clobetasol Propionate To Enhance Its Permeation Using Silk Sericin As Permeation Enhancer. Int J Pharm Sci Res. 2020;11:2356\u201365. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.11(5).2356-65.","journal-title":"Int J Pharm Sci Res"},{"key":"3037_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-35767-4","volume":"13","author":"S Ramazi","year":"2023","unstructured":"Ramazi S, Salimian M, Allahverdi A, Kianamiri S, Abdolmaleki P. Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line. Sci Rep. 2023;13:1\u201313. https:\/\/doi.org\/10.1038\/s41598-023-35767-4.","journal-title":"Sci Rep"},{"key":"3037_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0927-7765(03)00080-8","volume":"30","author":"A Manosroi","year":"2003","unstructured":"Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30:129\u201338. https:\/\/doi.org\/10.1016\/S0927-7765(03)00080-8.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"3037_CR45","doi-asserted-by":"publisher","first-page":"109958","DOI":"10.1016\/j.msec.2019.109958","volume":"104","author":"M Upadhyay","year":"2019","unstructured":"Upadhyay M, Adena SKR, Vardhan H, Yadav SK, Mishra B. Locust bean gum and sodium alginate based interpenetrating polymeric network microbeads encapsulating Capecitabine: Improved pharmacokinetics, cytotoxicity & in vivo antitumor activity. Mater Sci Eng C. 2019;104:109958. https:\/\/doi.org\/10.1016\/j.msec.2019.109958.","journal-title":"Mater Sci Eng C"},{"key":"3037_CR46","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/03639045.2018.1451880","volume":"44","author":"B Amiri","year":"2018","unstructured":"Amiri B, Ahmadvand H, Farhadi A, Najmafshar A, Chiani M, Norouzian D. Delivery of vinblastine-containing niosomes results in potent in vitro\/in vivo cytotoxicity on tumor cells. Drug Dev Ind Pharm. 2018;44:1371\u20136. https:\/\/doi.org\/10.1080\/03639045.2018.1451880.","journal-title":"Drug Dev Ind Pharm"},{"key":"3037_CR47","doi-asserted-by":"publisher","first-page":"120686","DOI":"10.1016\/j.molliq.2022.120686","volume":"368","author":"S Somjid","year":"2022","unstructured":"Somjid S, Shinsuphan N, Temprom LSK. Effects of cholesterol and temperature on structural properties and dynamic behavior of niosome bilayers with melatonin Inclusion: A Coarse-Grained simulation study. J Mol Liq. 2022;368:120686.","journal-title":"J Mol Liq"},{"issue":"2","key":"3037_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/ph12020046","volume":"12","author":"LK Yeo","year":"2019","unstructured":"Yeo LK, Chaw CS, Elkordy AA. The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharm. 2019;12(2):46. https:\/\/doi.org\/10.3390\/ph12020046.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"3037_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pharmaceutics11020055","volume":"11","author":"X Ge","year":"2019","unstructured":"Ge X, Wei M, He S, Yuan WE. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharm. 2019;11(2):55. https:\/\/doi.org\/10.3390\/pharmaceutics11020055.","journal-title":"Pharmaceutics"},{"key":"3037_CR50","doi-asserted-by":"publisher","first-page":"101581","DOI":"10.1016\/j.jddst.2020.101581","volume":"56","author":"P Bhardwaj","year":"2020","unstructured":"Bhardwaj P, Tripathi P, Gupta R, Pandey S. Niosomes: A review on niosomal research in the last decade. J Drug Deliv Sci Technol. 2020;56:101581. https:\/\/doi.org\/10.1016\/j.jddst.2020.101581.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3037_CR51","doi-asserted-by":"publisher","first-page":"e07968","DOI":"10.1016\/j.heliyon.2021.e07968","volume":"7","author":"T Barot","year":"2021","unstructured":"Barot T, Rawtani D, Kulkarni P. Development, characterization and in vitro\u2013in vivo evaluation of Farnesol loaded niosomal gel for applications in oral candidiasis treatment. Heliyon. 2021;7:e07968. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07968.","journal-title":"Heliyon"},{"key":"3037_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-26400-x","volume":"12","author":"A Haddadian","year":"2022","unstructured":"Haddadian A, Robattorki FF, Dibah H, Soheili A, Ghanbarzadeh E, Sartipnia N, et al. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. Sci Rep. 2022;12:1\u201316. https:\/\/doi.org\/10.1038\/s41598-022-26400-x.","journal-title":"Sci Rep"},{"key":"3037_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-43755-w","volume":"9","author":"M Barani","year":"2019","unstructured":"Barani M, Mirzaei M, Torkzadeh-Mahani M, Adeli-sardou M. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells: Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay. Sci Rep. 2019;9:1\u201310. https:\/\/doi.org\/10.1038\/s41598-019-43755-w.","journal-title":"Sci Rep"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03037-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:31:12Z","timestamp":1740504672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03037-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"62"}}